Paul Matthews, OBE, M.D., DPhil, FRCP, FMedSci
Imperial College London, UK
Paul MATTHEWS, OBE, MA, DPhil, M.D. (Stanford), FRCPC, FRCP, FMedSc, is the Edmond and Lily Safra Professor of Translational Neuroscience and Therapeutics, Head of the Department of Brain Sciences, Director of the UK Dementia Research Institute and Chair of the UKRI Medical Research Council Neurosciences and Mental Health Board. He is an NIHR Senior Investigator.
Since 2009, he has been on the Steering Committee of UK Biobank and chairs the Imaging Enhancement Working Group, which has supported UK Biobank for creating the world’s largest imaging epidemiological dataset.The UK Biobank Imaging Study aims to carry out detailed MRI imaging analyses of vital organs in over 100,000 participants, the largest of its kind in the world. His research also focuses on innovative translational applications of clinical imaging for neuroscience. He was a founding director of two international research imaging centres, the University of Oxford Centre for Functional Magnetic Resonance of the Brain and later the GlaxoSmithKline Clinical Imaging Centre. From 2005 to 2014, he was Vice President of GlaxoSmithKline Medicines Discovery and Development.
Previously, Prof. Matthews spent almost 9 years as a Vice President in GlaxoSmithKline, holding a variety of senior portfolios, including those for the GSK Clinical Imaging Centre and the later Global Imaging Group. He is a Fellow of the Academy of Medical Sciences, a Fellow by Special Election of St Edmund Hall, Oxford and a Fellow of the Academea Europea. He was awarded an OBE in 2008 for services to Neuroscience.